Modulation of Nrf2/Keap1/HO-1 signaling treats cardiovascular diseases by alleviating oxidative stress in cardiomyocytes, enhancing the cellular antioxidant defense system, and upregulating the viability of cardiomyocytes. The gene discussed is KEAP1; the disease is cardiovascular disorder.